The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world data comparing FOLFIRINOX versus gemcitabine nab-paclitaxel as first-line treatment of metastatic pancreatic ductal adenocarcinoma patients in the United States.
 
Avital Klein-Brill
No Relationships to Disclose
 
Shlomit Amar-Farkash
Employment - Anthem Inc.
 
Gabriella Lawrence
Employment - Anthem Blue Cross Blue Shield
 
Eric Andrew Collisson
Stock and Other Ownership Interests - BloodQ; Clara Health; Guardant Health; HDT Bio; Hint Health; IHP Therapeutics; One Medical; Tatara Therapeutics; Valar Labs
Research Funding - AstraZeneca (Inst); Ferro Oncology/Bridge Bio (Inst); Loxo/Bayer (Inst); Merck KGaA (Inst)
Expert Testimony - NantBioScience
 
Michael Jordan Fisch
Employment - AIM Specialty Health
Stock and Other Ownership Interests - Anthem
Patents, Royalties, Other Intellectual Property - Healthcore, Inc. A subsidiary of Anthem, Inc.
 
Dvir Aran
Employment - Anthem Inc.; Anthem Israel
Speakers' Bureau - CytoReason